Dermatologic issues in adult survivors of childhood cancer

Kinahan, Karen E.; Gandhi, Mona A.; Lacouture, Mario E.; Eilers, Robert; Haryani, Anand; Didwania, Aarati; Sharp, Lisa K.

doi:10.1007/s11764-009-0091-4

Cited by 8 publications

(4 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…2014a), one used at least one telephone reminder (participation rate 43%) (Kinahan et al . ) and 10 studies used a combination of postal and telephone reminders (median participation rate 62.5%, range 39–91%) (Mertens et al . ; Larcombe et al .…”

Section: Resultsmentioning

confidence: 99%

Participation rates of childhood cancer survivors to self-administered questionnaires: a systematic review

et al. 2016

View full text Add to dashboard Cite

This review aimed to assess participation rates of childhood cancer survivors (CCS) invited to fill out a health-related questionnaire. Additionally, effects of study and CCS characteristics on participation rates were examined. PubMed, Web of Science, Ovid (EMBASE) and CINAHL databases were searched. Publications included were questionnaire-based studies among CCS diagnosed with cancer before the age of 21, alive at least 5 years past diagnosis and aged 16 years or older at the time of study. Thirty-five studies were included; the median participation rate was 65%. Sixteen studies reported information about CCS actively declining participation (median rate 5%). Five study characteristics seemed to influence participation rates: the use of reminders and incentives, the option to answer a shortened questionnaire, the recruitment of participants through their general practitioner and a pre-notification before sending out the questionnaire. Furthermore, CCS characteristics related to improved participation were female gender, Caucasian ethnicity and a higher educational level. The results of this study will help to improve the (methodological) quality of future questionnaire-based studies among CCS, thereby increasing our knowledge about late effects among this group of survivors.

show abstract

Section: Resultsmentioning

confidence: 99%

Participation rates of childhood cancer survivors to self-administered questionnaires: a systematic review

et al. 2016

View full text Add to dashboard Cite

show abstract

“…112 Ongoing dermatologic concerns that impact QoL or self-esteem are common among childhood cancer survivors. 4,113 Additionally, pediatric cancer patients are at higher risk of developing secondary skin cancers due to genetic cancer predisposition syndromes and treatment exposures such as radiotherapy. 114 Early referral to a pediatric dermatologist in those experiencing cAEs that may affect function or QoL can help improve therapeutic compliance and prevent the need for antineoplastic therapy dose modification.…”

Section: Discussionmentioning

confidence: 99%

“…Long‐term survival rate among pediatric patients with cancer is approximately 80% 112 . Ongoing dermatologic concerns that impact QoL or self‐esteem are common among childhood cancer survivors 4,113 . Additionally, pediatric cancer patients are at higher risk of developing secondary skin cancers due to genetic cancer predisposition syndromes and treatment exposures such as radiotherapy 114 .…”

Section: Discussionmentioning

confidence: 99%

Dermatologic toxicities of targeted antineoplastic agents and immune checkpoint inhibitor therapy in pediatric patients: A systematic review

Liu

Teng

Spunt

et al. 2021

Pediatric Blood & Cancer

View full text Add to dashboard Cite

Cutaneous adverse events (cAEs) from targeted antineoplastic agents and immune checkpoint inhibitors are common in children with cancer and may lead to dose reduction or cessation of critical oncologic treatment. Timely diagnosis and proper management of cAEs in pediatric oncology patients is essential to optimize ongoing cancerdirected therapy and improve quality of life. This systematic review of published studies summarizes dermatologic toxicities to targeted anticancer treatments and immune checkpoint inhibitors.

show abstract

“…Patients were worried that hair might not grow back (Kim et al, 2012). Although losing hair usually will recover over time, a report of adult survivors of childhood cancer documented that in fact 10% of survivors were affected by prolonged alopecia after treatment completion (Kinahan et al, 2009). Future studies exploring specific challenges families face when their child has chemotherapy-induced alopecia would be of benefit to better understand the needs of parents and patients.…”

Section: Discussionmentioning

confidence: 99%

Parents' and Health-Care Providers' Perspectives on Side-Effects of Childhood Cancer Treatment in Indonesia

Gunawan¹,

Wolters²,

Dongen³

et al. 2014

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

Asian Pac J Cancer Prev, 15 (8), 3593-3599 IntroductionChildhood cancer survival is lower in low-income countries (<35%) than in high-income countries (80%) (Mostert et al., 2011;Rohani-Rasaf et al., 2012). Several factors contribute to this discrepancy: death from toxicity, relapse and non-adherence. Treatment abandonment, a severe form of non-adherence and seldom seen in high-income countries, is the most prominent factor. Recently, various studies indicated that nonadherence and abandonment are not merely caused by socio-economic hardships, but also by psychological aspects and side-effects of chemotherapy (Yeh et al., 1999;De Oliveira et al., 2005;Bonilla et al., 2009;Sitaresmi et al., 2010;Wang et al., 2011).Chemotherapy-related side-effects may deteriorate the child's quality of life and hinder families' acceptance and adherence with prescribed medication (Yeh et al.,1999;

show abstract

Dermatologic issues in adult survivors of childhood cancer

Abstract: Childhood cancer survivors may frequently seek care from primary care providers. It is important for these providers to be aware of the risks associated with cancer treatments.

Cited by 8 publications

References 18 publications

Participation rates of childhood cancer survivors to self-administered questionnaires: a systematic review

Participation rates of childhood cancer survivors to self-administered questionnaires: a systematic review

Dermatologic toxicities of targeted antineoplastic agents and immune checkpoint inhibitor therapy in pediatric patients: A systematic review

Parents' and Health-Care Providers' Perspectives on Side-Effects of Childhood Cancer Treatment in Indonesia

Contact Info

Product

Resources

About